TickerFacts.

Orasure Technologies Inc (OSUR): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$61.78M
Year ended 2025-12-31
-$44.45M
Trailing 12 months to 2026-06-30
$53.62M2009-12-31: -$5.74M2010-12-31: -$342.0K2011-12-31: -$4.51M2012-12-31: -$9.02M2013-12-31: -$5.61M2014-12-31: $1.50M2015-12-31: $13.86M2016-12-31: $25.95M2017-12-31: $46.31M2018-12-31: $34.88M2019-12-31: $25.95M2020-12-31: $4.21M2021-12-31: $1.49M2022-12-31: -$6.85M2023-12-31: $53.62M2024-12-31: -$17.38M2025-12-31: -$61.78M-$61.78M
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$61.78Mn/m2026-03-09, From 2025-01-01
2024-12-31-$17.38Mn/m2026-03-09, From 2024-01-01
2023-12-31$53.62Mn/m2026-03-09, From 2023-01-01
2022-12-31-$6.85Mn/m2025-03-07, From 2022-01-01
2021-12-31$1.49M-64.5%2024-03-11, From 2021-01-01
2020-12-31$4.21M-83.8%2023-03-03, From 2020-01-01
2019-12-31$25.95M-25.6%2022-03-01, From 2019-01-01
2018-12-31$34.88M-24.7%2021-03-01, From 2018-01-01
2017-12-31$46.31M+78.5%2020-03-02, From 2017-01-01
2016-12-31$25.95M+87.2%2019-02-28, From 2016-01-01
2015-12-31$13.86Mn/c2018-02-28, From 2015-01-01
2014-12-31$1.50Mn/m2017-03-14, From 2014-01-01
2013-12-31-$5.61Mn/m2016-03-14, From 2013-01-02
2012-12-31-$9.02Mn/m2015-03-12, From 2012-01-01
2011-12-31-$4.51Mn/m2014-03-14, From 2011-01-01
2010-12-31-$342.0Kn/m2013-03-13, From 2010-01-01
2009-12-31-$5.74Mn/a2012-03-14, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Orasure Technologies Inc (OSUR)2025-12-31-$61.78Mn/m
Anika Therapeutics, Inc. (ANIK)2025-12-31-$5.68Mn/m
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$12.51Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$126.03Mn/m
InfuSystem Holdings, Inc (INFU)2025-12-31$25.21M+30.0%
Neuronetics, Inc. (STIM)2025-12-31-$27.97Mn/m
Iradimed Corp (IRMD)2025-12-31$27.31M+19.9%
PRO DEX Inc (PDEX)2026-06-30$14.38M+20.6%
Sight Sciences, Inc. (SGHT)2025-12-31-$36.61Mn/m

Compare OSUR, ANIK, XTNT, KMTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗